Protagonist Therapeutics, Inc Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Protagonist Therapeutics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Protagonist Therapeutics, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $10.2M, a 50.3% increase year-over-year.
  • Protagonist Therapeutics, Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $35.1M, a 24.3% increase year-over-year.
  • Protagonist Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $29.3M, a 21% increase from 2022.
  • Protagonist Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $24.2M, a 47.6% increase from 2021.
  • Protagonist Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $16.4M, a 108% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $29.3M +$5.09M +21% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $24.2M +$7.81M +47.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $16.4M +$8.5M +108% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $7.9M -$454K -5.44% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $8.35M +$1.43M +20.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.92M +$2.68M +63.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $4.24M +$2.11M +99.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 $2.13M +$2.03M +2052% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $99K +$57K +136% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $42K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.